11. 重症筋無力症 Myasthenia gravis Clinical trials / Disease details

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-003272-41-DK (EUCTR)	15/06/2022	02/11/2021	A study to examine the efficacy and safety of pozelimab and cemdisiran combination therapy in patien ...	Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients with Symptomatic Gen ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Pozelimab Product Code: REGN3918 INN or Proposed INN: Pozelimab Product Name: Cemdisiran P ...	Regeneron Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	235	Phase 3	Serbia;United States;Czechia;Taiwan;Spain;Turkey;United Kingdom;Italy;India;France;Canada;Belgium;Br ...
2	EUCTR2020-003272-41-DE (EUCTR)	04/03/2022	04/01/2022	A study to examine the efficacy and safety of pozelimab and cemdisiran combination therapy in patien ...	Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients with Symptomatic Gen ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Pozelimab Product Code: REGN3918 INN or Proposed INN: Pozelimab Product Name: Cemdisiran P ...	Regeneron Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	235	Phase 3	United States;Czechia;Taiwan;Spain;Ukraine;Russian Federation;United Kingdom;Italy;France;Canada;Pol ...
3	EUCTR2020-003272-41-ES (EUCTR)	03/02/2022	28/09/2021	A study to examine the efficacy and safety of pozelimab and cemdisiran combination therapy in patien ...	Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients with Symptomatic Gen ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Pozelimab Product Code: REGN3918 INN or Proposed INN: Pozelimab Product Name: Cemdisiran P ...	Regeneron Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	210	Phase 3	United States;Czechia;Taiwan;Spain;Ukraine;Russian Federation;United Kingdom;Italy;France;Canada;Pol ...
4	EUCTR2020-003272-41-PL (EUCTR)	01/12/2021	21/10/2021	A study to examine the efficacy and safety of pozelimab and cemdisiran combination therapy in patien ...	Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients with Symptomatic Gen ...	Generalized Myasthenia Gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Pozelimab Product Code: REGN3918 INN or Proposed INN: Pozelimab Product Name: Cemdisiran P ...	Regeneron Pharmaceuticals, Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	210	Phase 3	United States;Czechia;Taiwan;Spain;Ukraine;Russian Federation;United Kingdom;Italy;France;Canada;Pol ...

First Previous1Next Last